How to build the perfect search strategy: Local databases
02
March, 2019
Literature monitoring
Depending on the client and substance, literature monitoring requires you to screen local databases. Each database differs from one another, and each has its own quirks and qualities. We can’t make a unified list of recommendations. But we can list some workarounds for common challenges.

The biggest challenge of local database searches is not the local language. It’s making sure they include all relevant findings.
We’ve already got a closer look at building your search strategy in PubMed. So how much different can it be in any other database?
First of all, there are so many local databases that are drastically distinct from one another. From span to language, there are many things to look out for. But they often have certain characteristics in common. And there are specific challenges that come with working in local databases. That’s why we’ll first list, then elaborate on them in this article.
I. Get to know your local database
The geographic area it covers
The answer to this question defines the languages you should use in a search, the scope of its results and the overall impact on the healthcare system.
The scientific area, too
Depending on the database, you might not have access to all relevant articles related to the substance or medicinal product you’re monitoring. The database could be narrowed to a specific medicinal discipline, or it could be broader than that.
Some collect content from a narrow niche, while others may include papers from various other scientific areas, including the humanities, arts or technical sciences. While there might be some information related to a substance’s safety profile, it is highly unlikely this information would be usable.
Overlap with other databases
The bigger array of information you gather, the better. Using two databases can result in an overlap of information that can slow and even hinder your safety monitoring. It can only lead to unnecessary duplicates without adding anything to the process.
Duplicates can be a wrench in your workflow. It’s easy to lose time on them, and they do not look well on audits. That’s why Sympto® has its own processes that identify and warn you of any possible duplicates you’ve entered. It calculates the possibility that a case you entered is a duplicate.
User interface
Appraise the search engines functions. Is it intuitive and easy to use? The flow of your monitoring will largely depend on this. Some steps in the search process could either help or hinder you, depending on your query and substances you cover.
Access
Some bases like MEDLINE are open to the wider public. Some require specific conditions before using them. Access to its articles or even abstracts can vary depending on them. Make sure if it grants you access to the full body of text, the title and an abstract, or just the title.
Searching through local databases has its quirks. In the next few steps we’ll take a look at the main differences and how to approach them.
II. Differences in research
Different databases require specialized approaches. We’ve already established that there can be no universally prescribed workflow for them.
However, there are some common pressure-points in the majority of the local databases you can use. From filtering to linguistic quirks, let’s take a closer look at some patterns that we can take advantage of:

Period workaround
This complicates weekly searches for regular clients. You have to be punctual. So how can you easily pin down articles that appeared in a week, if you can’t narrow your search?
Keep a weekly updated checklist for each article. This gives you a clear and easy overview of articles that surface from week to week, and you can immediately identify a new addition. Once you notice a change of number in your checklist, you’ll know that there is a new article and find it without any headaches.
However, you have to be careful. Relying on the number of articles can turn into a slippery slope if the database you are using has the option of retrieving published articles. And we deal with this problem in our next workaround.


Withdrawal workaround
Checking if there are any new articles on your regular weekly or monthly screening could sound easy if you keep a checklist as we suggested. Just check if there was an increase in number from last week, and you’re done.
However, a number of databases tend to withdraw articles. Not just local databases, even MEDLINE does it. Check if this is the practice of your local database. If it is, screening by numbers on your checklists is not an acceptable solution.
To counter possible mistakes or overlooks, keep the title and a detailed description of the study on your checklists. This way, you’ll recognize any withdrawals or adjustions and pinpoint them in no time. In the end, it’s best to read through the articles to recognize changes in available information.


Subject workaround
Some search engines will give you hits related to biosciences and medicine. However, many other databases include literature from other scientific areas. They could cover everything from theological to technical sciences. In the majority of cases, these types of articles contain next to nothing relevant for the substance’s safety profile. However, you can’t completely sign them off.
It’s best to recognize the source for what it is, keep the information you find with a grain of salt, yet read through it to be completely sure there is not even a small particle of information you could use. Sometimes, they could surprise you with a valuable reference.

More advice on literature monitoring?
No matter the difference between one database and the next, literature monitoring always follows the same bottom line. Take only what is relevant. Communicate with your colleagues for feedback. Research. Stay informed.
And after finishing your search, it’s time to weigh and make sense of the material. Read up on recognizing relevant literature in our previous article.
Want to know more about this topic or about Sympto®?
We invite you to connect with us or download our study checklists to make your literature screening easier.
© 2019 Marti Farm Ltd. All rights reserved.
No part of this publication may be reproduced or transmitted in any form or for any purpose without the express permission of Marti Farm.
The information contained herein may be changed without prior notice. Some software products marketed by Marti Farm contain proprietary software components of other software vendors.
National product specifications may vary.
These materials are provided by Marti Farm for informational purposes only, without representation or warranty of any kind, and Marti Farm shall not be liable for errors or omissions with respect to the materials. The only warranties for Marti Farm products and services are those that are set forth in the express warranty statements accompanying such products and services, if any. Nothing herein should be construed as constituting an additional warranty.
In particular, Marti Farm have no obligation to pursue any course of business outlined in this document or any related presentation, or to develop or release any functionality mentioned therein. This document, or any related presentation, and Marti Farm’s strategy and possible future developments, products, and/or platform directions and functionality are all subject to change and may be changed by Marti Farm at any time for any reason without notice. The information in this document is not a commitment, promise, or legal obligation to deliver any material, code, or functionality. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Readers are cautioned not to place undue reliance on these forward-looking statements, and they should not be relied upon in making purchasing decisions.
Marti Farm products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of Marti Farm in Croatia and other countries. All other product and service names mentioned are the trademarks of their respective companies.